Evaluating harm reduction services for people who use drugs.
Assessing the Reach, Effectiveness, and Implementation of Multiple Harm Reduction Interventions.
This study is looking at different support services in San Francisco that help people who use drugs, like syringe programs and overdose education, to see how well they work and how they can be improved to keep everyone healthier and safer.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Research Triangle Institute NIH-funded |
| Lab location | 1 site (Research Triangle Park, United States) |
| Project ID | NIH-10587283 on NIH RePORTER |
What this research studies
This research investigates various harm reduction services aimed at improving the health of individuals who inject or smoke illicit drugs in San Francisco. It focuses on assessing the reach, effectiveness, adoption, implementation, and maintenance of these services, which include syringe service programs, overdose education, and safe consumption sites. By analyzing the impact of these interventions, the study aims to provide valuable insights into how to better support this vulnerable population and reduce health complications associated with drug use.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who inject or smoke illicit drugs and are seeking harm reduction services.
Not a fit: Patients who do not use illicit drugs or are not engaged in harm reduction services may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved health outcomes and reduced mortality for individuals who use illicit drugs.
How similar studies have performed: Previous research has shown success in implementing harm reduction strategies, indicating that this approach is both tested and promising.
Where this research is happening
Research Triangle Park, United States
- Research Triangle Institute — Research Triangle Park, United States (Active)
Researchers
- Principal investigator: Kral, Alexander H — Research Triangle Institute
- Study coordinator: Kral, Alexander H
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.